Nemolizumab & Waxing: 2026 Skin Safety Rules

The persistent itch and inflammation of atopic dermatitis can be debilitating, deeply impacting quality of life. For many years, treatment options were limited, but the advent of biologics like nemolizumab has offered new hope, specifically targeting the IL-31 receptor to alleviate the intense pruritus that defines the condition. However, as medical advancements progress, patients often face new questions about how these treatments interact with routine personal care practices. One such question, surprisingly common in my practice, revolves around waxing safety: can individuals on nemolizumab safely wax? I recall a recent case involving Sarah, a 34-year-old client who had battled severe atopic dermatitis since childhood. Her arms, legs, and even parts of her torso were often marked by dry, eczematous patches, making her self-conscious and limiting her clothing choices. For years, she avoided any hair removal method beyond careful shaving, which often exacerbated her skin irritation. When her dermatologist prescribed nemolizumab in late 2024, Sarah experienced a significant reduction in itching and overall skin improvement within a few months. Her skin, while still prone to dryness, felt less inflamed, and the constant urge to scratch had diminished dramatically. This newfound relief prompted a desire for other aspects of personal care she had long forgone, including professional waxing. Sarah approached me with trepidation, explaining her medication regimen and her history of sensitive skin. She was clear about her primary concern: would waxing undo the progress she had made with nemolizumab? My immediate advice, as it always is in such situations, was to consult her prescribing dermatologist. While I can offer insights into skin reactions to waxing, only her doctor could provide a definitive medical clearance regarding her specific condition and medication. This is a critical point. We, as practitioners, must understand the boundaries of our expertise. Nemolizumab, a monoclonal antibody, works by blocking the signaling of interleukin-31 (IL-31), a cytokine heavily implicated in the itch-scratch cycle of atopic dermatitis. By interrupting this pathway, it reduces the severity of pruritus and, consequently, the skin damage caused by scratching. The drug doesn’t directly affect the skin’s structural integrity or its healing capacity in the same way some topical steroids might, but it does modulate the inflammatory response. This means Sarah’s skin was still inherently sensitive due to her underlying atopic dermatitis, even if the symptoms were well-controlled. The potential for irritation, erythema, or even a flare-up post-waxing remained a legitimate concern. After her consultation, Sarah returned with a cautious green light from her dermatologist. The doctor emphasized a few key points: communication was paramount, a patch test was non-negotiable, and we should use the gentlest methods available. This collaborative approach between patient, dermatologist, and esthetician is, in my opinion, the gold standard for managing personal care for individuals with complex skin conditions. Our first session focused on a small, inconspicuous area on her inner forearm. We chose a hard wax formulation. Unlike soft wax, which adheres to both hair and skin, hard wax primarily encapsulates the hair as it cools and hardens, lifting it away from the skin without significant epidermal exfoliation. This is an important distinction for anyone with sensitive or compromised skin barriers, as the mechanical stress on the skin is considerably reduced. Before application, I carefully cleansed the area with a mild, alcohol-free cleanser and ensured it was completely dry. Excess moisture, even residual water from cleansing, can interfere with wax adhesion and increase the likelihood of skin lifting or irritation, especially on delicate skin. The temperature of the wax was also carefully monitored. Overheating is a common pitfall that can lead to burns or exacerbate existing inflammation. The patch test yielded promising results. There was some expected transient redness, but no prolonged irritation, excessive itching, or signs of an allergic reaction. This positive outcome gave Sarah the confidence to proceed with larger areas. We started with her lower legs, which had fewer active lesions and were generally less reactive than her arms. During the full waxing session, I maintained a strict protocol. Each strip was applied and removed swiftly, always against the direction of hair growth, to minimize skin trauma. Post-waxing, I immediately applied a soothing, fragrance-free balm containing ingredients like aloe vera and chamomile. These ingredients are known for their anti-inflammatory and calming properties, helping to reduce redness and replenish the skin’s moisture barrier. One common mistake I see, particularly with at-home waxing, is neglecting proper aftercare. For someone like Sarah, whose skin barrier is already compromised by atopic dermatitis, this step is arguably as important as the waxing itself. I advised her to avoid hot showers, tight clothing, and harsh exfoliants for at least 24 to 48 hours. Instead, gentle cleansing with lukewarm water and continued application of her prescribed emollients were recommended. Sun exposure was another concern. Freshly waxed skin is more susceptible to sunburn, so I stressed the importance of broad-spectrum SPF 30 or higher. The follow-up was encouraging. Sarah reported minimal discomfort and no significant flare-ups. She continued her nemolizumab treatment as prescribed, and the combination of effective medical management and careful waxing practices allowed her to achieve smoother, hair-free skin without compromising her dermatological progress. Her experience shows a vital principle: medical treatments for conditions like atopic dermatitis don’t necessarily preclude personal care services, but they demand a more informed, cautious, and collaborative approach. It’s also worth considering the psychological impact. For many individuals with chronic skin conditions, regaining control over aspects of their appearance, even something as routine as hair removal, can significantly boost self-esteem and overall well-being. Sarah expressed a renewed sense of confidence, something she hadn’t felt in years. This emotional component should never be underestimated in the well-rounded care of patients. While Sarah’s case was successful, it’s important to acknowledge that not every individual on nemolizumab, or with atopic dermatitis in general, will have the same experience. Skin sensitivity varies widely. Some patients might have more widespread or severe disease, or be on concomitant medications that could increase skin fragility. Therefore, individualized assessment and a cautious approach are always necessary. My professional opinion is that waxing can be a viable option for individuals with atopic dermatitis, even those on biologics like nemolizumab, provided several conditions are met. First, explicit medical clearance from a dermatologist is non-negotiable. Second, the choice of wax formulation matters significantly; hard wax is almost always preferable. Third, careful technique, including proper skin preparation and swift removal, minimizes trauma. Fourth, diligent aftercare, focusing on soothing and barrier repair, is essential. Finally, the patch test isn’t just a suggestion. It’s a critical safety measure that provides invaluable information about how an individual’s skin will react. Ignoring this step is, frankly, irresponsible.

The field of dermatology is constantly evolving, and with new treatments come new considerations for everyday practices. As practitioners, our responsibility extends beyond the immediate service to understanding the broader health context of our clients. Staying informed about emerging medications and their potential implications for skin health is not merely good practice. It is fundamental to providing safe and effective care. Sarah’s journey from chronic discomfort to confident skin is proof of what can be achieved when medical advice and professional care converge thoughtfully. For anyone considering waxing while on nemolizumab or similar treatments, the path forward involves open communication with your healthcare provider and your esthetician. Do not assume your skin will react the same way it did before treatment, or even the same way as someone else on the same medication. Every individual’s skin is unique, and personalized care is the most effective approach. In summary, managing personal care like waxing for clients on medications such as nemolizumab requires a detailed understanding of the medication’s effects, careful consideration of skin health, and a commitment to rigorous safety protocols. This includes mandatory dermatologist consultation, careful patch testing, and the use of appropriate techniques and products to support the skin barrier.